Novel therapeutic approach for neurogenic erectile dysfunction: effect of neurotrophic tyrosine kinase receptor type 1 monoclonal antibody.
Lin G, Li H, Zhang X, Wang J, Zaid U, Sanford MT, Tu V, Wu A, Wang L, Tian F, Kotanides H, Krishnan V, Wang G, Ning H, Banie L, Lin CS, Deng GG, Lue TF.
Eur Urol. 2015 Apr;67(4):716-26. doi: 10.1016/j.eururo.2014.10.013. Epub 2014 Oct 25.
PMID:25847857
Neuroanatomy and neurophysiology related to sexual dysfunction in male neurogenic patients with lesions to the spinal cord or peripheral nerves.
Everaert K, de Waard WI, Van Hoof T, Kiekens C, Mulliez T, D'herde C.
Spinal Cord. 2010 Mar;48(3):182-91. doi: 10.1038/sc.2009.172. Epub 2010 Jan 5.
PMID:20048757
Neurogenic ejaculatory disorders: focus on current and future treatments.
Calabrò RS, Polimeni G, Ciurleo R, Casella C, Bramanti P.
Recent Pat CNS Drug Discov. 2011 Sep 1;6(3):205-21. doi: 10.2174/157488911796958011.
PMID:21834782
[Erectile and Ejaculatory Dysfunction].
Gross O, Sulser T, Eberli D.
Praxis (Bern 1994). 2015 Nov 25;104(24):1337-41. doi: 10.1024/1661-8157/a002194.
PMID:26602851
Lower urinary tract and sexual dysfunction in neurological patients.
A 12-Week, Open Label, Multi-Center Study to Evaluate the Clinical Efficacy and Safety of Silodosin on Voiding Dysfunction in Patients with Neurogenic Bladder.
Moon KH, Park CH, Jung HC, Oh TH, Kim JS, Kim DY.
Low Urin Tract Symptoms. 2015 Jan;7(1):27-31. doi: 10.1111/luts.12044. Epub 2013 Nov 19.